ArticleBMJ neurology open2025

Reversible cerebral vasoconstriction syndrome in idiopathic multicentric Castleman disease under treatment with tocilizumab.

Naoya Kamimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.